Re-mark
Oral Mucositis (OM) Market Size & Share Analysis Oral Mucositis refers to erythematous and ulcerative lesions of the oral mucosa observed in patients with cancer being treated with chemotherapy, and/or with radiation therapy to fields involving the oral cavity.In 2017, the total incident cases of Oral Mucositis in the seven major markets was 1,418,879. Similarly, the total treated cases of Oral Mucositis in the 7MM was 1,021,399. As per the Delveinsight, the therapeutic market of Oral Mucositis in the 7MM was USD 1,052.7 million in 2017, which is expected to increase during the forecast period. The key players involved in developing therapies for Oral Mucositis includes Innovation Pharmaceuticals, Enzychem Lifesciences Corporation, BrainCool, NeoMedLight, Monopar Therapeutics, MuReva (Lumitex), EpicentRx/Prothex Pharma, Soligenix, Galera Therapeutics and others. Source: https://www.delveinsight.com/report-store/oral-mucositis-om-market
You may like
Matte Visiting Cards
#MatteVisitingCards, #MatteFinish, #ElegantBusinessCards, #SmoothTouch, #PremiumQuality, #CustomMatteCards, #ModernDesign
Glossy Business Cards
#GlossyBusinessCards, #HighGlossFinish, #ShinyBusinessCards, #LuxuryVisitingCards, #PremiumPrinting, #ProfessionalDesign, #VibrantColors
Eco-Friendly Business Card
#EcoFriendlyBusinessCards, #SustainableDesign, #RecycledPaperCards, #GreenPrinting, #EcoBranding, #BiodegradableCards, #EnvironmentFriendly